Navigation Links
Most generalists reluctant to provide primary care for young adults with chronic illness
Date:7/29/2008

The majority of general internists and pediatricians in the United States are not comfortable serving as primary care providers for young adults with complex chronic illnesses that originate during childhood, according to findings from a new national survey.

The survey, conducted by researchers at the University of California, San Francisco and the University of Michigan, examined a random sample of internists and pediatricians to assess their comfort levels in treating young adult patients with cystic fibrosis (CF) and sickle cell disease (SCD) two hereditary diseases that involve single gene mutations.

"My interest is in how to improve the quality of care for youth and young adults with childhood onset chronic diseases," said Megumi Okumura, MD, lead author of the paper who is an assistant professor in pediatrics at UCSF and treats patients at UCSF Children's Hospital. "These individuals are a unique bunch, because they are born with their diseases, and the health care services they receive as children are not necessarily matched in the adult health care setting."

Survey findings showed that only 15 percent of the general internists said they would be comfortable providing primary care to young adult CF patients, while 32 percent reported being comfortable providing care for those with SCD. Among the pediatricians surveyed, 38 percent said they would be comfortable serving as the primary care provider for CF patients, while 35 percent said the same for treating patients with SCD.

Both the internists and pediatricians reported that they would be more comfortable treating young adults with common diseases, such as asthma and hypertension, than treating patients with a history of CF and SCD.

Findings from the survey are currently available online at http://www.springerlink.com/content/rj738l32700m35k1/ and will be published in the October issue
'/>"/>

Contact: Kate Schoen
kschoen@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Recent Safety News About Smoking Cessation Therapies Leaving Smokers Confused, More Reluctant to Quit
2. Out-of-hours doctors reluctant to do home visits, say patients
3. Out of hours doctors reluctant to do home visits, say patients
4. Providence Service Corporation Sees Budget Clarity Improving Toward Year End With Budget Issues Impacting Second Quarter and Balance of 2008
5. Study provides clues to preventing and treating cancer spread
6. HTH Worldwide to Provide International Health Guide to Living Abroad.com
7. Connecticut State Medical Society Chooses gloStream as a Preferred Electronic Medical Record and Practice Management Solutions Provider
8. Air Methods Provides 2nd Quarter Update and Date of Quarterly Conference Call
9. Childrens National Medical Center Program Director to Provide Expertise to DiabeTeens.com, The HealthCentral Networks Teen Diabetes Site
10. MitoAction Develops On-Line Resource for Mitochondrial Disease Care Providers
11. Fat Grafting Provides Permanent, Natural Looking Results - Dr. Michael Law Explains Fat Injections as a New Trend in Facial Plastic Surgery

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...t their response to a "cocaine-cues" video, active...s activity in brain regions linked to drug craving...of Energy,s Brookhaven National Laboratory. The re...uroImage , suggest that clinical interventions des...ld help cocaine abusers stop using drugs and avoid...
(Date:11/30/2009)...nd dessert at the holiday table are even less of a...ccording to a new research report recently appeari...bj.org ), a diet that is high in fat and in sugar ...ur bodies to store too much fat. This means these ...difficult task of converting high-fat and high-sug...
(Date:11/30/2009)...avily more often than younger people, study finds,...- Older people who are problem drinkers consume mo...report finds, possibly because they need more alco... a study released this month, people dependent on ... drinks a week, on average. By contrast, younger a...
(Date:11/30/2009).... Rappa, MD, explores the intricate connection bet...ealing Heart to Soul: One Doctor’s Journey o...9). , Dallas, TX (Vocus) ... let go of negative emotions, whether caused by us...oulders. Oftentimes, this disease of the human spi...
(Date:11/30/2009)..., Nov. 30 Baxa Corporation is spon... "culture of safety" means in today,s pharmacy env...eating a Culture of Safety in Pharmacy ," features... their experiences with culture of safety, what it...d the role of technology in enabling or inhibiting...
Breaking Medicine News(10 mins):Health News:Brain scan study shows cocaine abusers can control cravings 2Health News:Brain scan study shows cocaine abusers can control cravings 3Health News:Western diets turn on fat genes 2Health News:Binge Drinking Not Just a Rite of the Young 2Health News:Healing from the Inside Out: Compelling New Book Explores the Intricate Connection between Body, Soul, and Better Health 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3
..., Rockville, Md., September 24, 2008 The U.S. Ph...e the release of its first Certified Reference Mat...cently became the first global pharmacopeia to rec... with a new class of reference standard that ensur...
..., The depth of transmural tumor invasion along th...al lymph nodes constitute major factors in the pro...rative staging of rectal cancer carries a crucial ...rated well in the literature. However, studies com...
..., Black Americans have a higher occurrence of col...nificant finding considering the incidence of colo...d unchanged among black women during the last 20 y...d A. Lieberman, M.D., head of gastroenterology, Or...
...Pioneer of concierge medicine selects finest local...cago practice, BELLEVUE, Wash., Sept. 24 MD2 Int...ned a Chicago practice with two of the,area,s fine...hysicians and expand its network., "Many of the f...
...Panel of ALS Researchers to Present and Consider t...., Sept. 24 The ALS Therapy,Development Institute...annual ALS research symposium, part of the fourth ...cientists will provide,presentations on the develo...
...Deal Marks First High-Definition Interactive Syste...thcare Facility Deployment, SIOUX FALLS, S.D., Se...t Interactive Corporation (Nasdaq: LNET ),announc...sity HealthSystem facilities in the Chicago area. ...
Other Medicine News:Health News:Which is more accurate on diagnosis of rectal carcinoma? 2Health News:Black Americans are at higher risk for colon polyps 2Health News:MD2 International Brings Highly Attentive Medicine to Chicago 2Health News:ALS Patients and Researchers Unite in Boston for 4th Annual Leadership Summit 2Health News:ALS Patients and Researchers Unite in Boston for 4th Annual Leadership Summit 3Health News:ALS Patients and Researchers Unite in Boston for 4th Annual Leadership Summit 4Health News:LodgeNet Healthcare Signs New Agreement with NorthShore University HealthSystem 2Health News:LodgeNet Healthcare Signs New Agreement with NorthShore University HealthSystem 3
(Date:11/30/2009)... , , INDIANAPOLIS, Nov. 30 /PRNew...tration (FDA) has approved Cymbalta® (duloxet...zed anxiety disorder (GAD) in adults, Eli Lilly an...ince generalized anxiety disorder can be a chronic...atients find a treatment option that is effective ...
(Date:11/30/2009)... , , THOUSAND OAKS, Calif., Nov. 30 /PR... today announced that it will present updated long...omiplostim) in adult chronic immune (idiopathic) t... will present the first Nplate study in a pediatri...tic syndromes (MDS) at the 2009 American Society o...
(Date:11/29/2009)... , , CHICAGO, Nov. 30 Rad...is from a remote location with the use of a handhe...ftware, according to a study presented today at th...rth America (RSNA). ,, "The goal is to improve...ell as to improve communications among different c...
Breaking Medicine Technology:FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5Amgen Highlights Data to be Presented at ASH 2Amgen Highlights Data to be Presented at ASH 3Amgen Highlights Data to be Presented at ASH 4Amgen Highlights Data to be Presented at ASH 5Amgen Highlights Data to be Presented at ASH 6Amgen Highlights Data to be Presented at ASH 7Amgen Highlights Data to be Presented at ASH 8Amgen Highlights Data to be Presented at ASH 9Amgen Highlights Data to be Presented at ASH 10Amgen Highlights Data to be Presented at ASH 11Smart Phones Allow Quick Diagnosis of Acute Appendicitis 2Smart Phones Allow Quick Diagnosis of Acute Appendicitis 3LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 1LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 2LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 3LG Electronics Introduces New Flat Panel HDTVs Designed Specifically for Long Term Care Facilities 53486 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 1SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 2SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 3SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 4SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS 13331 5PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 1PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 2
..., Fla. , May 29 GlaxoSmithKline [NYSE: GSK] and ...ted States Food and Drug Administration,s (FDA) On...o three that the ARZERRA(TM) (ofatumumab) data are... patients with chronic lymphocytic leukemia (CLL) ...mtuzumab. Ofatumumab is an investigational treatme...
...VILLE, Pa., May 29 Wyeth Pharmaceuticals, a divis...minary data from two ongoing studies, one evaluati...umab (Herceptin(R), Roche) in HER-2 positive (ErbB...nvestigating neratinib safety and efficacy when gi...b) in patients with HER-2 dependent solid tumors. ...
Other Medicine Technology:FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 2FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 3FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 4FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 5New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 2New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 3New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 4New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer 5
7121B Sony Medical Monitor
...ompletely new and revolutionary lens system. The u... size without distortion. The 115 field of view su...tion of the telescope. Beyond that a new quick loc... is introduced. It is the combination of outstandi...
...e the surgeon with an optimal work area and reduce...t and retinal surgery. Perfect Pupil Injectable is...pils which allows expansion of the pupil to 8mm co...gery, and allows the pupil to return to its normal...
Defiant 95% Bag Filter
Medicine Products: